Sandoz Eyes First-To-Market US Opportunities With Adalvo Deal

Targeting Six Antifungal/Antibiotic, Oncology And Pulmonary Drugs Worth $3bn

 
• By Dave Wallace
  
Dice showing all sixes
Sandoz has struck a deal with Adalvo for six products • Source: Shutterstock

More from Deals

More from Business